Back to top

Bernstein Sticks to Its Hold Rating for Astellas Pharma (ALPMF)

Bernstein analyst Miki Sogi maintained a Hold rating on Astellas Pharma today and set a price target of Yen2,200.00. Sogi covers the Healthcare sec...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Astellas Pharma Inc. (ALPMY)